New malaria vaccine trial aims to stop parasite in its tracks
NCT ID NCT05380388
First seen Mar 29, 2026 · Last updated May 25, 2026 · Updated 10 times
Summary
This study tests a new vaccine (PvRII/Matrix-M) to see if it is safe and can slow down the malaria parasite in the blood. About 36 healthy Thai adults aged 20-55 will take part; half get the vaccine and half get a placebo. After three doses, some volunteers will be exposed to the malaria parasite in a controlled setting to measure how well the vaccine works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA VACCINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faculty of Tropical Medicine
Bangkok, 10400, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.